The last 10 global press releases

To find more press releases: 

2022
2021
2020
2019
2018
2017
2016
August 11, 2022
Press releases
Sanofi Media Update
August 8, 2022
Press releases
Media Update: Tolebrutinib clinical trial program update
August 4, 2022
Press releases
Press Release: Sanofi and Innovent Biologics enter strategic collaboration to accelerate development of oncology medicines and expand presence in China
July 28, 2022
Press releases
Press Release: Strong execution in Q2 drives full-year 2022 guidance upgrade and delivers rich R&D news flow in Immunology and Rare Disease
July 14, 2022
Press releases
Press Release: Dupixent® (dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis
July 10, 2022
Press releases
Press Release: Fitusiran prophylaxis reduced bleeds by 61% in people with hemophilia A or B, with or without inhibitors, compared to prior factor or bypassing agent prophylaxis
July 10, 2022
Press releases
Press Release: Pivotal data demonstrate once-weekly efanesoctocog alfa provides superior bleed protection compared to prior factor prophylaxis
July 4, 2022
Press releases
Sanofi Global Health launches nonprofit Impact® brand for 30 medicines in low-income countries
June 30, 2022
Press releases
Media Update: Patient enrollment of phase III tolebrutinib trials paused in the U.S.
June 28, 2022
Press releases
Press Release: Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease